Meeder Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,942
| Closed | -$6.47K | – | 948 |
|
|
2024
Q4 | $6.47K | Buy |
+2,942
| New | +$6.47K | ﹤0.01% | 787 |
|
|
2020
Q2 | – | Sell |
-580
| Closed | -$18K | – | 2168 |
|
|
2020
Q1 | $18K | Buy |
+580
| New | +$18K | ﹤0.01% | 1280 |
|
|
2019
Q1 | – | Sell |
-98
| Closed | -$5K | – | 1741 |
|
|
2018
Q4 | $5K | Buy |
+98
| New | +$5K | ﹤0.01% | 1405 |
|
|
2018
Q2 | – | Sell |
-404
| Closed | -$30K | – | 1592 |
|
|
2018
Q1 | $30K | Buy |
404
+33
| +9% | +$2.45K | ﹤0.01% | 783 |
|
|
2017
Q4 | $25K | Buy |
371
+114
| +44% | +$7.68K | ﹤0.01% | 869 |
|
|
2017
Q3 | $13K | Buy |
257
+158
| +160% | +$7.99K | ﹤0.01% | 1011 |
|
|
2017
Q2 | $5K | Sell |
99
-15
| -13% | -$758 | ﹤0.01% | 1188 |
|
|
2017
Q1 | $4K | Sell |
114
-2,842
| -96% | -$99.7K | ﹤0.01% | 1153 |
|
|
2016
Q4 | $37K | Buy |
+2,956
| New | +$37K | ﹤0.01% | 591 |
|